LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription.

Chun Lan Kang,Bing Qi,Qian Qian Cai,Li Sheng Fu,Ying Yang,Chang Tang,Ping Zhu,Qi Wen Chen,Jing Pan,Mei Hua Chen,Xing Zhong Wu
DOI: https://doi.org/10.7150/thno.32854
IF: 11.6
2019-01-01
Theranostics
Abstract:Rationale: Tumor metastasis is the main cause for cancer-related death. However, the driving molecules of metastasis remain largely unknown. Here, we aim to identify long non-coding RNAs (lncRNAs) critical for human hepatocellular carcinoma (HCC) metastasis. Methods: Microarrays were used to screen a comprehensive set of lncRNAs with differential expression profiles in sulfatide-treated cells. Mass spectrometry, protein arrays, and RNA pull-down experiments were used to identify proteins that interacted with lncRNA. Epigenetic analysis was used to study lncRNA-mediated regulation mechanisms. Results: We identified lncRNA AY927503 (AY) as a metastasis-associated molecule that was highly expressed in human hepatocellular carcinoma (HCC) and correlated with metastatic events and poor prognosis in patients with HCC. AY promoted HCC cell migration, stemness, 5-fluorouracil resistance, and metastasis in mice. However, knockdown of integrin alpha V (ITGAV) abolished AY-stimulated migration, cell viability in HCC cells or tube formation. AY strongly promoted ITGAV transcription and alpha V beta 3 expression by interacting with the ITGAV promoter specifically and stimulating its activity. AY was identified to interact with histone 1 FX (H1FX), but deletion of the central domain of AY (AY Delta 371-522) abolished H1FX binding and ITGAV promoter stimulation. AY significantly enriched H3K4Me3 and acH3K9/14 but reduced H3K27Me3 and H1FX occupancy on the ITGAV promoter, which remodeled chromatin structures for RNA polymerase II recruitment. Knockdown of H1FX abrogated ITGAV transcription stimulated by AY. Conclusions: Our findings suggested that lncRNA AY promoted HCC metastasis via induction of chromatin modification for ITGAV transcription as a pioneer factor and was a potential molecular signature for metastasis or poor prognosis in patients with HCC.
What problem does this paper attempt to address?